Author: Canadian Institute for Substance Use Research
The Canadian Institute for Substance Use Research, formerly CARBC, is a member of the BC Partners for Mental Health and Addictions Information. The institute is dedicated to the study of substance use in support of community-wide efforts aimed at providing all people with access to healthier lives, whether using substances or not. For more, visit www.cisur.ca.
What is the legal status (and evidence) of CBD oil?
All cannabinoids, including CBD, produce effects in the body by attaching to certain receptors in the brain or immune system. The human body also produces its own cannabinoids. It seems that CBD does not attach directly to receptors. Instead, it directs the body to use more of its own cannabinoids to produce the therapeutic effects associated with CBD.
Because of the way cannabis and its products are metabolized, scientists believe there is a potential for interaction with other drugs, although nothing significant has yet been recorded. CBD has been found to be generally safe. Reports from patients indicate that negative drug interactions are not common. As with any other treatment, it is important to monitor your use of CBD and seek assistance if you experience any problems or have questions or concerns about its use.
Research suggests that CBD may provide relief for chronic pain. Sativex is a proprietary medication that combines THC and CBD and may be prescribed for the relief of pain associated with multiple sclerosis. There is also some evidence suggesting that CBD may be a promising support for people with opioid use disorders. The researchers noted that CBD reduced some symptoms associated with substance use disorders including anxiety, mood-related symptoms, pain, and insomnia.
Only limited parts of cannabis or hemp plants may be used in a:
Cannabis oil is a combination of:
CBD is currently a controlled substance under the Single Convention. CBD products may therefore only be imported or exported under very specific conditions. Any import or export must meet all of these criteria and may only be done:
CBD and prescription drugs
Before the Cannabis Act came into force, CBD was:
The provinces and territories are responsible for determining how cannabis is distributed and sold within their jurisdictions.
As a result, CBD and products containing CBD are subject to all of the rules and requirements that apply to cannabis under the Cannabis Act and its regulations. This includes CBD derived from industrial hemp plants, as well as CBD derived from other varieties of cannabis.
You must have a processing licence to manufacture products containing CBD for sale, no matter what the source of the CBD is.